Mohamed S A Elsayed

Title: **Inventor Spotlight: Mohamed S A Elsayed**

Introduction

Mohamed S A Elsayed is an accomplished inventor based in West Lafayette, IN, USA. He has made significant contributions to the field of pharmacology, particularly through his innovative work on delta-opioid receptor agonists. With a total of four patents to his name, Elsayed's research aims to address critical health issues, including alcohol use disorders and co-occurring psychiatric disorders.

Latest Patents

Elsayed's latest patents focus on the development of novel δ-opioid receptor agonists. These compounds are characterized by their selective action on δ-opioid receptors and exhibit either substantially no or low beta-arrestin 2 recruitment. The applications of these innovative agonists present promising therapeutic avenues for treating alcohol use disorders and associated psychiatric conditions.

Career Highlights

Throughout his career, Mohamed S A Elsayed has collaborated with prestigious organizations, including the Purdue Research Foundation and the United States of America, as represented by the Secretary, Department of Health and Human Services. His work reflects his dedication to advancing medical science and improving patient outcomes through novel therapeutics.

Collaborations

Elsayed has had the opportunity to work alongside esteemed colleagues such as Mark Stanley Cushman and Richard M Van Rijn. These collaborations have been instrumental in furthering his research and enhancing the development of his patented innovations.

Conclusion

In summary, Mohamed S A Elsayed stands out as a notable inventor with a focus on innovative therapeutic solutions. His work on δ-opioid receptor agonists not only demonstrates his expertise but also highlights his commitment to addressing significant health challenges. As he continues to push the boundaries of pharmacological research, Elsayed's contributions will likely lead to impactful advancements in treatment options for various disorders.